Ageing populations, the growing prevalence of chronic disease, greater use of expensive treatments, and expanding public healthcare coverage are stretching existing healthcare resources more »

Whether the target is a new drug or new capital, business development and licensing deals pump lifeblood into pharma companies of all sizes more »